XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.00 (0.00%)
Close on Nov 13, 2026Market cap $59.76MP/E –Yield –
XBiotech total assets
Total assets on the balance sheet at the end of each period.
XBiotech's total assets was $128.61M at Sep 30, 2026. For fiscal 2025 it was $150.08M, down 24.6% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is $816.88M in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $150.08M | -24.6% |
| FY2024 | Dec 31, 2024 | $199.09M | -12.1% |
| FY2023 | Dec 31, 2023 | $226.62M | -7.9% |
| FY2022 | Dec 31, 2022 | $246.10M | -10.6% |
| FY2021 | Dec 31, 2021 | $275.18M | -22.2% |
| FY2020 | Dec 31, 2020 | $353.74M | -56.7% |
| FY2019 | Dec 31, 2019 | $816.88M | +1742.1% |
| FY2018 | Dec 31, 2018 | $44.35M | -29.6% |
| FY2017 | Dec 31, 2017 | $62.97M | -6.1% |
| FY2016 | Dec 31, 2016 | $67.05M | -38.7% |
| FY2015 | Dec 31, 2015 | $109.36M | +75.9% |
| FY2014 | Dec 31, 2014 | $62.18M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $128.61M | -25.4% |
| Q2 FY2026 | Jun 30, 2026 | $133.65M | -25.2% |
| Q1 FY2026 | Mar 31, 2026 | $139.84M | -23.1% |
| Q4 FY2025 | Dec 31, 2025 | $150.08M | -24.6% |
| Q3 FY2025 | Sep 30, 2025 | $172.42M | -17.8% |
| Q2 FY2025 | Jun 30, 2025 | $178.68M | -17.1% |
| Q1 FY2025 | Mar 31, 2025 | $181.86M | -20.2% |
| Q4 FY2024 | Dec 31, 2024 | $199.09M | -12.1% |
| Q3 FY2024 | Sep 30, 2024 | $209.85M | -8.6% |
| Q2 FY2024 | Jun 30, 2024 | $215.56M | -8.3% |
| Q1 FY2024 | Mar 31, 2024 | $227.86M | -5.9% |
| Q4 FY2023 | Dec 31, 2023 | $226.62M | -7.9% |
| Q3 FY2023 | Sep 30, 2023 | $229.60M | -8.5% |
| Q2 FY2023 | Jun 30, 2023 | $235.14M | -11.8% |
| Q1 FY2023 | Mar 31, 2023 | $242.12M | -10.6% |
| Q4 FY2022 | Dec 31, 2022 | $246.10M | -10.6% |
| Q3 FY2022 | Sep 30, 2022 | $250.83M | -10.3% |
| Q2 FY2022 | Jun 30, 2022 | $266.46M | -24.7% |
| Q1 FY2022 | Mar 31, 2022 | $270.80M | -23.9% |
| Q4 FY2021 | Dec 31, 2021 | $275.18M | -22.2% |
| Q3 FY2021 | Sep 30, 2021 | $279.52M | -20.9% |
| Q2 FY2021 | Jun 30, 2021 | $353.96M | -1.3% |
| Q1 FY2021 | Mar 31, 2021 | $355.94M | -0.7% |
| Q4 FY2020 | Dec 31, 2020 | $353.74M | -56.7% |
| Q3 FY2020 | Sep 30, 2020 | $353.39M | +430.3% |
| Q2 FY2020 | Jun 30, 2020 | $358.76M | +399.1% |
| Q1 FY2020 | Mar 31, 2020 | $358.37M | +799.9% |
| Q4 FY2019 | Dec 31, 2019 | $816.88M | +1742.1% |
| Q3 FY2019 | Sep 30, 2019 | $66.64M | +35.3% |
| Q2 FY2019 | Jun 30, 2019 | $71.88M | +32.4% |
| Q1 FY2019 | Mar 31, 2019 | $39.82M | -32.3% |
| Q4 FY2018 | Dec 31, 2018 | $44.35M | -29.6% |
| Q3 FY2018 | Sep 30, 2018 | $49.24M | -30.3% |
| Q2 FY2018 | Jun 30, 2018 | $54.29M | -30.3% |
| Q1 FY2018 | Mar 31, 2018 | $58.86M | -32.8% |
| Q4 FY2017 | Dec 31, 2017 | $62.97M | -6.1% |
| Q3 FY2017 | Sep 30, 2017 | $70.67M | – |
| Q2 FY2017 | Jun 30, 2017 | $77.84M | – |
| Q1 FY2017 | Mar 31, 2017 | $87.62M | – |
| Q4 FY2016 | Dec 31, 2016 | $67.05M | – |
See a number that looks wrong?